BMI View: Ghana is strategically positioned in Sub-Saharan Africa, and is rapidly gaining prominence as an entry point for investors keen to work in the region. Its healthcare and pharmaceutical sectors have strong growth prospects, fuelled by the expansion of a national health insurance scheme, a growing middle class and increased government spending. In addition, the government is keen to support national drugmaking facilities. One lingering concern relates to the presence of counterfeit drugs, although much progress is being made in this area. Boosting local production would help reduce the risks in the supply chain: many substandard drugs are imported, …
Order / Buy a copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=107767.
Complete report details with Table of Contents and more @ http://www.rnrmarketresearch.com/ghana-pharmaceuticals-and-healthcare-report-q3-2013-market-report.html.
No comments:
Post a Comment